However, a clinical trial evaluating hypsarrhythmia severity using a specific scale demonstrated significant improvement in the group treated with prednisolone compared with ACTH, suggesting that corticosteroids may offer additional benefits when assessed with detailed metrics. The gene discussed is POMC; the disease is Hypsarrhythmia.